1. Home
  2. OMF vs PRAX Comparison

OMF vs PRAX Comparison

Compare OMF & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMain Holdings Inc.

OMF

OneMain Holdings Inc.

HOLD

Current Price

$54.58

Market Cap

8.3B

Sector

Finance

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$330.00

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMF
PRAX
Founded
1920
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
9.6B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
OMF
PRAX
Price
$54.58
$330.00
Analyst Decision
Buy
Strong Buy
Analyst Count
12
15
Target Price
$69.17
$572.13
AVG Volume (30 Days)
1.6M
364.5K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
7.65%
N/A
EPS Growth
54.72
N/A
EPS
6.56
N/A
Revenue
N/A
N/A
Revenue This Year
$71.78
N/A
Revenue Next Year
$6.89
$6,395.88
P/E Ratio
$8.37
N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.00
$26.70
52 Week High
$71.93
$354.87

Technical Indicators

Market Signals
Indicator
OMF
PRAX
Relative Strength Index (RSI) 33.90 53.52
Support Level $51.93 $290.36
Resistance Level $61.14 N/A
Average True Range (ATR) 1.88 18.34
MACD -0.02 -2.56
Stochastic Oscillator 18.21 57.24

Price Performance

Historical Comparison
OMF
PRAX

About OMF OneMain Holdings Inc.

OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company's reportable segment is Consumer and Insurance. The main source of revenue is net interest income.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: